Peptide sequencing using Continuity miniature mass spectrometer

Importance of the Topic

Peptide sequencing by mass spectrometry is a cornerstone of proteomics, underpinning applications ranging from biomarker discovery to quality control in biopharmaceuticals. Portable, battery-operated instruments expand this capability to field settings, enabling rapid on-site analysis without the need for centralized laboratories.

Objectives and Study Overview

This application note demonstrates the use of the BaySpec Continuity™ miniature mass spectrometer for sequencing peptides in a standard mixture. The study aims to showcase sample preparation, MSn acquisition, and sequence assignment for a complex peptide, highlighting the instrument’s portability and analytical performance.

Methodology

Peptides from a Sigma-Aldrich mixture (H2016) were dissolved in HPLC-grade water and diluted with a 50:50 methanol:water solution containing 0.5% acetic acid. The resulting solution was directly infused into the instrument’s atmospheric pressure inlet without further cleanup or separation. Key analytical steps included:

• Full-scan MS1 acquisition over m/z 110–950 to detect intact peptide ions
• SWIFT isolation of target precursor ions (e.g., DRVYIHPF at m/z 524.2) for tandem analysis
• Collisionally induced dissociation (CID) in the linear ion trap to generate MS2 spectra
• Assignment of a-, b-, and y-type fragment ions to confirm peptide sequence

Used Instrumentation

• BaySpec Continuity™ portable mass spectrometer (22 kg, battery powered)
• Linear ion trap analyzer with MSn capability
• Continuous atmospheric pressure sampling inlet with differential pumping
• Wide mass range detection (110–950 amu)

Main Results and Discussion

MS1 analysis produced clear peaks corresponding to individual peptides in the mixture. The doubly charged peptide DRVYIHPF (m/z 524.2) was isolated using SWIFT and fragmented via CID. The resulting MS2 spectrum contained well-resolved a, b, and y ions, allowing unambiguous sequence assignment. These results confirm the instrument’s sensitivity, resolution, and suitability for reliable peptide identification in non-laboratory environments.

Benefits and Practical Applications

Key advantages of this approach include:

• Rapid, on-site peptide sequencing without chromatography
• Portability for field diagnostics, environmental monitoring, and forensic analysis
• Support for quality assurance in bioprocessing and pharmaceutical manufacturing
• Reduced turnaround time from sample collection to result interpretation

Future Trends and Potential Applications

Advances in miniaturized mass spectrometry will likely focus on higher resolving power, enhanced ion optics, and integration with microfluidic separation technologies. Coupling portable MS with machine-learning-based data analysis could enable real-time proteome profiling for clinical, environmental, and defense applications.

Conclusion

The BaySpec Continuity™ miniature mass spectrometer demonstrates robust peptide sequencing capabilities in a compact, field-deployable format. Its performance in MSn experiments validates its potential for expanding proteomic analyses beyond traditional laboratory environments.